Delaware bills · 153rd General Assembly (2025-2026)
Delaware HB 466
AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE APPLICATION OF NASAL EPINEPHRINE.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Ray Seigfried (Democratic)
- David P. Sokola (Democratic)
- DeShanna U Neal (Democratic)
Summary
Official abstract published by the Delaware legislature· synopsis
This Act adds authority and guidelines for access to and use of intranasal epinephrine nasal sprays at institutions of higher education to the existing framework for access to and use of epinephrine injectors. This Act also removes the requirement of the Department of Public Health from filing an annual report regarding the use of epinephrine autoinjectors for the prior academic year with the General Assembly under this section.
Text versions
Roll-call votes
State vote data last updated Oct 15, 2026, 4:08 AM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Jun 30, 2026 Senate | 3/4 | pass | Set your home in Delaware to see |
| Jun 11, 2026 House | 3/4 | pass | Set your home in Delaware to see |
Actions
- Jul 23, 2026
Signed by Governor - Jun 30, 2026 · Senate
Passed By Senate. Votes: 21 YES - Jun 24, 2026 · Senate
Reported Out of Committee (Health & Social Services) in Senate with 6 On Its Merits - Jun 11, 2026 · Senate
Assigned to Health & Social Services Committee in Senate - Jun 11, 2026 · House
Passed By House. Votes: 38 YES 1 NO 2 ABSENT - Jun 9, 2026 · House
Reported Out of Committee (Health & Human Development) in House with 1 Favorable, 10 On Its Merits - Jun 4, 2026 · House
Introduced and Assigned to Health & Human Development Committee in House